期刊文献+

吉林省初治涂阳结核病患者分离株耐药谱研究 被引量:2

A study on drug-resistance patterns of isolates in patients with initial smear positive tuberculosis in Jilin
原文传递
导出
摘要 目的分析吉林省初治涂阳结核病患者的耐药谱资料,为耐药结核病防治工作提供参考依据。方法采用比例法对吉林省30个耐药监测点初治涂阳结核病患者分离株,进行异烟肼(INH)、利福平(RFP)、乙胺丁醇(EMB)、链霉素(SM)、氧氟沙星(OFX)、卡那霉素(KM)药物敏感性试验,分析结核分枝杆菌原发性耐药情况及影响因素。结果纳入初治涂阳1 200例患者,培养阳性菌株1 175株,阳性率为97.9%;对INH、RFP、EMB、SM、OFX、KM耐药率分别为17.19%(202/1 175)、10.47%(123/1 175)、4.34%(51/1 175)、26.30%(309/1 175)、5.62%(66/1 175)、3.74%(44/1 175);原发性耐药率为58.2%。结论吉林省结核病患者的耐药率日益趋高,初治涂阳结核病耐药率高,应加强结核病耐药监测,有效预防和控制结核病及耐药结核病的产生和蔓延。 Objective To survey and analyze the data of the dug- resistance pattern of the initial smear positive tuberculosis( TB) patients in Jilin. To provide reference for prevention and treatment of tuberculosis. Methods Using the proportion method for drug susceptibility testing of of isoniazide( INH),rifampicin( RFP),ethambutol( EMB),streptomycin( SM),ofloxacin( OFX) and kanamycin( KM) isolated from initial smear- positive TB patients in 30 drug resistance surveillance stations of Jilin. MTB primany drug- resistance of Mycobacterium tuberculosis and its effects were analyzed. Results Collected 1 200 cases of initial smear- positive patients,1 175 cases were cultured positive,the positive rate was 97. 9%; The drug- resistant rates of MTB to INH,RFP,EMB,SM,OFX and KM were 17. 19%( 202 /1175),10. 47%( 123 /1175),4. 34%( 51 /1175),26. 30%( 309 /1175),5. 62%( 66 /1175),3. 74%( 44 /1175); Acquired initial drug resistance rate was 58. 2%. Conclusion TB drug- resistance rate of Jilin is growing increasingly high. Drug resistance rate of Jilin initial smear- positive patients is growing increasingly high,MTB resistance surveillance should be strengthened so as to effectively prevent and control the generation and spread of drug- resistant TB.
出处 《中国卫生检验杂志》 CAS 2015年第3期429-430,434,共3页 Chinese Journal of Health Laboratory Technology
基金 吉林省卫生厅招标科研课题(2010Z026)
关键词 结核分枝杆菌 结核病 耐药 Mycobacterium tuberculosis Tuberculosis Drug resistance
  • 相关文献

参考文献7

二级参考文献16

  • 1结核病诊断细菌学检验规程[J].中国防痨杂志,1996,18(1):28-31. 被引量:799
  • 2Global tuberculsis control: epidemiology, strategy, financing: WHO report 2009. Genera WHO/HTM/TB 2009: 411.
  • 3World Health Organization. Anti-tuberculosis drnug resistance in the world (report No 4). WHO/HTM/TB 2008:394.
  • 4The Global Plan to stop TB. 2006--2015. Genevs,WHO/HTM/ STB/2006 : 35.
  • 5中国疾病预防控制中心结核病预防控制中心(编译).结核病控制新技术,新技术采纳引进和实施框架.WHO/HTM/STB/2007.40.
  • 6TelentiA,ImbodenP,MarchexiF ,etal.Detectionofrifampicin-resistanacemutationsinmycobacteriumtuberculosis[].The Lancet.1993
  • 7HeymB,Al zariPM,HonoreN,etal.Missensemutationsinthecatalase-perox idasegene,KatG,areassociatedwithisoniazidresis tanceinMycobacteriumtuberculosis[].Molecular Microbiology.1995
  • 8Sre evatsanS,StockbaverKE,PanX,eta l.EthambutolresistanceinMycobacteriumtuberculosis:criticalroleofe mbBmutations[].Antimicrobial Agents and Chemotherapy.1997
  • 9Su llivanEA,KreiswirthBN,PalumboL,etal.Emergenceoffluoroquinolone-resistanttuberculosisinNewYorkCity[].The Lancet.1995
  • 10KapurV,LiLL,HamrickMR,etal.RapidMyocbacteriumspeciesassignmentandunambiguousidentificationofmutationsassociatedwithantibioticresistanceinMyocbacteriumtuberculosisbyautomatedDNAsequencing[].ArchPatholLabMed.1995

共引文献86

同被引文献31

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部